Page last updated: 2024-08-24

capecitabine and Gastric Diseases

capecitabine has been researched along with Gastric Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, S; Fujita, I; Horii, J; Matsueda, K; Murakami, T; Sakata, M; Toyokawa, T; Ueda, Y	1

Reviews

1 review(s) available for capecitabine and Gastric Diseases

Article	Year
Two cases of unresectable advanced HER2-positive gastric cancer perforation during chemotherapy with trastuzumab. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2017, Volume: 114, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Female; Humans; Intestinal Perforation; Male; Receptor, ErbB-2; Stomach; Stomach Diseases; Stomach Neoplasms; Trastuzumab; Treatment Outcome	2017

Article

Year

Two cases of unresectable advanced HER2-positive gastric cancer perforation during chemotherapy with trastuzumab.

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2017, Volume: 114, Issue:1

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Female; Humans; Intestinal Perforation; Male; Receptor, ErbB-2; Stomach; Stomach Diseases; Stomach Neoplasms; Trastuzumab; Treatment Outcome

2017